Page 1

Financial Statements for the Fiscal Year Ended December 31 , 2020 KOBAYASHI PHARMACEUTICAL CO . , LTD . Listed exchanges Listed company name Code URL Summary of Financial Statements ( Japanese GAAP ) ( Consolidated ) Financial Results for the Fiscal Year Ended December 31 , 2020 February 1 , 2021 Representative officer Contact Tel Expected date of general meeting of shareholders : March 26 , 2021 Expected date for starting payment of dividends : March 5 , 2021 Expected date for filing financial report with the Finance Ministry : March 26 , 2021 Preparation of supplementary explanation documents for Financial Statements : Yes Holding of an analyst meeting for the financial results : Yes ( For analysts and investors ) Net sales : Tokyo : Kobayashi Pharmaceutical Co. , Ltd. : 4967 : https://www.kobayashi.co.jp/english/index.html : Akihiro Kobayashi , President & COO : Satoshi Yamane , Senior Executive Director & Senior General Manager , Corporate Headquarters Operating income Ordinary income : + 81-6-6222-0142 1. Consolidated Results for Fiscal Year Ended December 31 , 2020 ( January 1 , 2020 to December 31 , 2020 ) ( 1 ) Consolidated Operating Results Return on assets Net income attributable to owners of the parent Net income per share Return on equity ( Any fraction less than 1 million yen is rounded down to the nearest million yen . ) ( % figures represent changes from previous period . ) FY ended December 31 , 2019 FY ended December 31 , 2020 150,514 millions ( 4.9 ) % of yen 25,943 1.1 27,726 19,205 245.71 yen ( 0.4 ) 0.3 0-1 10.8 11.7 158,340 millions of yen 25,658 27,851 19,139 244.08 yen 17.2 11.3 12.0 Ratio of operating income to net sales ( Note ) Comprehensive income FY ended December 31 , 2020 : 15,710 million yen ( -20.5 % ) FY ended December 31 , 2019 : 19,754 million yen ( 16.9 % ) % 16.2 ( Notes ) 1. The " Accounting Standard for Revenue Recognition " ( Accounting Standards Board of Japan ( ASBJ ) Statement No. 29 , March 30 , 2018 ) and " Implementation Guidance on the Accounting Standard for Revenue Recognition " ( ASBJ Guidance No. 30 , March 30 , 2018 ) have been early applied from the beginning of the fiscal year ended December 31 , 2020. In accordance with the basic treatment , the new accounting policy has been retrospectively applied to the results of previous fiscal years . Accordingly , the year - on - year percentage changes for the fiscal year ended December 31 , 2019 were retrospectively revised and have been omitted from the table above . 2. From the fiscal year ended December 31 , 2020 , the Company and its consolidated subsidiaries in Japan have changed the depreciation method for all property , plant and equipment to the straight - line method of depreciation . Furthermore , the service life of some property , plant and equipment and intangible assets has been changed in accordance with their actual service life . The amounts calculated based on the previous method ( the year - on - year percentage changes for the fiscal year ended December 31 , 2020 ) are provided below .